Monetizing Minors: Eric Befumo (aka Big Justice)
Brand partnerships worthy of a big “doom!”
StemGenex
A false advertising class-action lawsuit was filed against StemGenex Medical Group in August 2016 and transferred to federal court in November 2016. The complaint alleges that the company misleadingly markets its Stem Cell Treatments will treat diseases – including Alzheimer’s, Parkinson’s, and multiple sclerosis – and 100% of its prior customers are satisfied with its service without a reasonable basis for making such claims. In addition, the complaint alleges that the company omits important information about its Stem Cell Treatments, including the dissatisfaction and complaints of ineffectiveness from customers. (Moorer et al v. StemGenex Medical Group, Inc. et al, Case No. 16-cv-2816, S. D. CA.)
The Latest
Instacart’s AI-Enabled Pricing Experiments May Be Inflating Your Grocery Bill, CR and Groundwork Collaborative Investigation Finds
Derek Kravitz, Consumer Reports
Most Deceptive Ads of 2025
Here were some of the worst ads TINA.org investigated this year.
Cartice
Watch out for this company’s sketchy sale.
Worst False Ad Settlements of 2025
Some class-action settlements that left consumers out in the cold.